VEGFA and neoplasm: It works by binding to human vascular endothelial growth factor (VEGF) and blocks its biological activity to inhibit tumour angiogenesis (Garcia et al., 2020; Haunschild and Tewari, 2020; Nakai and Matsumura, 2022).